跳至主要内容
临床试验/NCT00781248
NCT00781248已完成2 期

Evaluation of Safety and Efficacy of the NasoGastric Shield (NG Shield) in Healthy Subjects With Indwelling Nasogastric Tube

Nanovibronix1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
Nanovibronix
入组人数
24
试验地点
1
主要终点
safety of device usage

研究概览

简要总结

The purpose of the study i to demonstrate the safety and efficacy of a device that intends to reduce pain/discomfort related to nasogfastric tube usage by reducing the friction between the tube and internal orifice (nose and pharynx)using micro vibrations

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is in good health and able to undergoes the NG tube insertion procedure, according to the PI decision
  • Subject is able to understand and answer the pain and discomfort questionnaires
  • Subject has been fasting for at least 12h prior to the insertion phase
  • Subject underwent a physical examination by the PI
  • Subject able, agrees and signs the Inform Consent Form (ICF)

排除标准

  • Subject has any history of dysphagia or esophageal disease
  • Subject used anti pain medications during the last week prior to the study date
  • Subject used Antibiotics during the last week prior to the study date
  • Subject with Asthma
  • Subject with chronic or acute nasal or throat disorder
  • Subject who suffered from upper respiratory infection at least 7 days prior to the insertion procedure
  • Any pain from other source prior to the initiation of the study procedure according to the PI judgment and decision
  • Subject has any condition, which precludes compliance with study and/or device instruction for use
  • Subject is currently participating in another clinical study

结局指标

主要结局

safety of device usage

时间窗: 6 hours

Pain/discomfort levelusing flicker scale (1-10 scale)during indwelling phase

时间窗: every 30 minutes for 6 hours

次要结局

  • pain/Dicomfort during insertion and removal of the nasogastric tube(at t=0h and t=6h)

研究者

发起方
Nanovibronix
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Safety and Efficacy Study of the NG Shield, a Device... | 临床试验